International Stem Cell Corp. (ISCO) to Launch New
Post# of 124
Posted On: 12/01/2015 4:16:45 PM
International Stem Cell Corp. (ISCO) to Launch New, Highly Lauded Skincare Product this Holiday Season
International Stem Cell Corp., a California-based biotech developing novel stem cell-based therapies and biomedical products, reports that its Lifeline Skin Care, Inc. subsidiary will launch its next generation skin care product in time for this year’s retail holiday season, which according to research from eMarketer will grow nearly 6% this year.
Starting in mid-December, U.S.-based consumers can purchase Molecular Renewal Serum™ through Lifeline’s website at www.lifelineskincare.com. Following product launches will target the domestic professional sales market such as luxury spas, aestheticians, and medical offices, as well as luxury skincare markets in Europe and Asia.
Molecular Renewal Serum is a collaboration between ISCO’s research and development team, which developed the breakthrough nano-compound technology behind the product, and a renowned cosmetic chemist who formulated the serum.
Independent third-party testing demonstrated that the new skin care product significantly improves skin elasticity and decreases skin roughness in all subjects four and eight weeks after the start of the study. Additionally, the compound-treated group outperformed the baseline as well as the Retinol treated group, without adverse events, such as skin irritation, which has been reported as a common side effect of Retinol treatment.
Lifeline’s current product line includes the Daily Defensive Complex, Recovery Night Moisture Serum, Eye Firming Complex, Dual Action Exfoliator, and Brightening Cleanser. In addition to the Molecular Renewal Serum, in 2015 Lifeline introduced two new products — Refresh Polishing Gelée and Neck Firming Complex.
ISCO’s confidence in Lifeline’s products is validated by professionals in the skin care industry.
Dr. Steven F. Weiner, MD, a facial plastic surgeon and pioneer in the field of minimally invasive cosmetic procedures, stated, “Our office has been using Lifeline Stem Cell Skin products for about four years. We have used it on freshly lasered and microneedled skin without complications and with improved healing times. All of our Infini patients have Lifeline applied and most continue to use it well after treatment because of the noted skin improvements it provides. It’s our best-selling growth factor product because of its higher concentrations of growth factors, streamlined product line and superior results.”
Jill Haynes, a Medical Aesthetician working under Jonathan Sykes, MD, a world renowned pioneer in facial plastic and reconstructive surgery research, at the University of California, Davis Medical Center recommends micro-needling treatments along with Lifeline Skincare products to her patients. “I am seeing incredible results in my patients. This is the biggest skin care breakthrough in years,” she says. “It’s not just about one product or procedure; it’s about using the best products and procedures in conjunction to create noticeable change in the skin.”
Lifeline has established a distribution network with global reach. Products are distributed domestically through the company’s branded website and network of dermatologists, plastic surgeons, and spas. On an international scale, Lifeline products are distributed through a network of local distributors. Shuei Trading Company, Lifeline’s largest international distributor, has introduced currently offered and custom-developed Lifeline products to the Japanese and Hong Kong markets.
Backed by a solid distribution network and growing family of breakthrough products, Lifeline has enjoyed rapid brand and product awareness since its inception five years ago, resulting in steady sales growth and operating income. So far this year, Lifeline has notched $2.6 million in revenue and remains on pace to achieve continued annual growth. Third-quarter revenues equaled $924,000, and the company forecasts even higher fourth-quarter sales.
In 2016, Lifeline plans to continue its upward growth trend with the introduction of several new products based on its proprietary extract and nano-compound technologies.
For more information, visit www.internationalstemcell.com and www.lifelineskincare.com
Please read full disclaimers at http://disclaimer.missionir.com
International Stem Cell Corp., a California-based biotech developing novel stem cell-based therapies and biomedical products, reports that its Lifeline Skin Care, Inc. subsidiary will launch its next generation skin care product in time for this year’s retail holiday season, which according to research from eMarketer will grow nearly 6% this year.
Starting in mid-December, U.S.-based consumers can purchase Molecular Renewal Serum™ through Lifeline’s website at www.lifelineskincare.com. Following product launches will target the domestic professional sales market such as luxury spas, aestheticians, and medical offices, as well as luxury skincare markets in Europe and Asia.
Molecular Renewal Serum is a collaboration between ISCO’s research and development team, which developed the breakthrough nano-compound technology behind the product, and a renowned cosmetic chemist who formulated the serum.
Independent third-party testing demonstrated that the new skin care product significantly improves skin elasticity and decreases skin roughness in all subjects four and eight weeks after the start of the study. Additionally, the compound-treated group outperformed the baseline as well as the Retinol treated group, without adverse events, such as skin irritation, which has been reported as a common side effect of Retinol treatment.
Lifeline’s current product line includes the Daily Defensive Complex, Recovery Night Moisture Serum, Eye Firming Complex, Dual Action Exfoliator, and Brightening Cleanser. In addition to the Molecular Renewal Serum, in 2015 Lifeline introduced two new products — Refresh Polishing Gelée and Neck Firming Complex.
ISCO’s confidence in Lifeline’s products is validated by professionals in the skin care industry.
Dr. Steven F. Weiner, MD, a facial plastic surgeon and pioneer in the field of minimally invasive cosmetic procedures, stated, “Our office has been using Lifeline Stem Cell Skin products for about four years. We have used it on freshly lasered and microneedled skin without complications and with improved healing times. All of our Infini patients have Lifeline applied and most continue to use it well after treatment because of the noted skin improvements it provides. It’s our best-selling growth factor product because of its higher concentrations of growth factors, streamlined product line and superior results.”
Jill Haynes, a Medical Aesthetician working under Jonathan Sykes, MD, a world renowned pioneer in facial plastic and reconstructive surgery research, at the University of California, Davis Medical Center recommends micro-needling treatments along with Lifeline Skincare products to her patients. “I am seeing incredible results in my patients. This is the biggest skin care breakthrough in years,” she says. “It’s not just about one product or procedure; it’s about using the best products and procedures in conjunction to create noticeable change in the skin.”
Lifeline has established a distribution network with global reach. Products are distributed domestically through the company’s branded website and network of dermatologists, plastic surgeons, and spas. On an international scale, Lifeline products are distributed through a network of local distributors. Shuei Trading Company, Lifeline’s largest international distributor, has introduced currently offered and custom-developed Lifeline products to the Japanese and Hong Kong markets.
Backed by a solid distribution network and growing family of breakthrough products, Lifeline has enjoyed rapid brand and product awareness since its inception five years ago, resulting in steady sales growth and operating income. So far this year, Lifeline has notched $2.6 million in revenue and remains on pace to achieve continued annual growth. Third-quarter revenues equaled $924,000, and the company forecasts even higher fourth-quarter sales.
In 2016, Lifeline plans to continue its upward growth trend with the introduction of several new products based on its proprietary extract and nano-compound technologies.
For more information, visit www.internationalstemcell.com and www.lifelineskincare.com
Please read full disclaimers at http://disclaimer.missionir.com
(0)
(0)Intl Stem Cell Corp (ISCO) Stock Research Links
Scroll down for more posts ▼